| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/17/2011 | CA2228221C Papillomavirus polyprotein constructs |
| 05/12/2011 | WO2011057301A1 Treatment of sleep disordered breathing with neurotoxin |
| 05/12/2011 | WO2011057267A1 Vaccine composition |
| 05/12/2011 | WO2011057224A2 Zwitterionic polymer bioconjugates and related methods |
| 05/12/2011 | WO2011057198A1 Vaccine testing system |
| 05/12/2011 | WO2011057188A1 Canine anti-cd20 antibodies |
| 05/12/2011 | WO2011057158A1 Treatment of paroxysmal nocturnal hemoglobinuria, hemolytic anemias and disease states involving intravascular and extravascular hemolysis |
| 05/12/2011 | WO2011057138A1 Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| 05/12/2011 | WO2011057124A1 Polyclonal bispecific antibody compositions and method of use |
| 05/12/2011 | WO2011057064A1 Igf1r inhibitor based treatment of prostate cancer |
| 05/12/2011 | WO2011057011A2 T-cell stimulating protein b and methods of use |
| 05/12/2011 | WO2011056899A2 Chimeric rsv-f polypeptide and lentivirus or alpha-retrovirus gag-based vlps |
| 05/12/2011 | WO2011056877A1 Malaria transmission-blocking vaccine |
| 05/12/2011 | WO2011056802A1 Influenza virus recombinant proteins |
| 05/12/2011 | WO2011056721A2 Immunoconjugates comprising poxvirus-derived peptides and antibodies against antigen-presenting cells for subunit-based poxvirus vaccines |
| 05/12/2011 | WO2011056697A1 Topical methods of treating rsv infections and related conditions |
| 05/12/2011 | WO2011056600A1 Human il-23 antigen binding proteins |
| 05/12/2011 | WO2011056502A1 Bone morphogenetic protein receptor type ii compositions and methods of use |
| 05/12/2011 | WO2011056234A1 Treatment for radiation-induced disorders |
| 05/12/2011 | WO2011056226A1 Adjuvanted nanoparticulate influenza vaccine |
| 05/12/2011 | WO2011056216A1 Plasmodium falciparum sporozoite and liver stage antigens |
| 05/12/2011 | WO2011056198A1 Monoclonal antibody binds antigen associated with human tumors |
| 05/12/2011 | WO2011056175A1 Methods of immunizing pregnant heifers at three months of gestation |
| 05/12/2011 | WO2011056060A2 Recombinant matrix protein of nipah virus |
| 05/12/2011 | WO2011055550A1 Therapeutic agent for autoimmune diseases or allergy, and method for screening for the therapeutic agent |
| 05/12/2011 | WO2011055398A1 A process for the production of immunoglobulines extracted from human plasma for therapeutic use, for the neutralization of the epstein-barr virus, and the medicine containing said immunoglobulins" |
| 05/12/2011 | WO2011054112A1 Antibodies that specifically block the biological activity of kidney associated antigen 1 |
| 05/12/2011 | WO2011054030A1 Treatment of cancer involving mutated kras or braf genes |
| 05/12/2011 | WO2011006084A3 Vaccines with oncofetal antigen/ilrp-loaded autologous dendritic cells and uses thereof |
| 05/12/2011 | WO2011003062A3 Probiotic compositions and processes thereof |
| 05/12/2011 | WO2010150982A9 Recombinant hemagglutinin protein having superior biocompatibility for an influenza virus vaccine, and method for preparing biodegradable plga microspheres containing same |
| 05/12/2011 | WO2010150233A3 Multimeric polypeptides of hla-g including at least two alpha3 domains and pharmaceutical uses thereof |
| 05/12/2011 | WO2010144908A3 Mammalian genes involved in tularemia and other infections |
| 05/12/2011 | WO2010130896A3 Method for admixing the lipopolysaccharide (lps) of gram-negative bacteria |
| 05/12/2011 | WO2010127166A4 Combination anti-hiv vectors, targeting vectors, and methods of use |
| 05/12/2011 | WO2010108245A3 Use of leishmania antigens in a diagnostic method, vaccine and therapy for leishmaniasis |
| 05/12/2011 | WO2010100200A3 Lyophilised antibody formulation |
| 05/12/2011 | WO2010100179A3 Self-forming gel system for sustained drug delivery |
| 05/12/2011 | WO2010027501A8 Anti-lipid antibodies |
| 05/12/2011 | US20110113497 Monoclonal antibodies against gonadotropin-releasing hormone receptor |
| 05/12/2011 | US20110112280 Use of rgm and its modulators |
| 05/12/2011 | US20110111528 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 05/12/2011 | US20110111036 Intracellular antibody delivery |
| 05/12/2011 | US20110111035 Inflammation-regulating compositions and methods |
| 05/12/2011 | US20110111017 Use of immunogenic compositions for the treatment or prevention of pathogen infections |
| 05/12/2011 | US20110111016 Non-dna base-containing polynucleotide compositions and their use for the modulation of immune responses |
| 05/12/2011 | US20110111015 Compositions and methods of enhancing immune responses to eimeria |
| 05/12/2011 | US20110111006 Conveniently implantable sustained release drug compositions |
| 05/12/2011 | US20110111003 Stable cell binding chimeric peptides |
| 05/12/2011 | US20110110983 Lactoferrin as an adjuvant in cancer vaccines |
| 05/12/2011 | US20110110982 Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae |
| 05/12/2011 | US20110110981 Orally Administerable Vaccine for Yersinia Pestis |
| 05/12/2011 | US20110110980 Heterlogous prime-boost immunization regimen |
| 05/12/2011 | US20110110979 Method and vaccine for optimizing the specific immune responses |
| 05/12/2011 | US20110110978 High titer recombinant influenza viruses with enhanced replication in vero cells |
| 05/12/2011 | US20110110977 Multiclade HIV Vaccines |
| 05/12/2011 | US20110110976 Rift valley fever virus-like particles and their use for immunization and as test system |
| 05/12/2011 | US20110110975 Inactivated virus compositions and methods of preparing such compositions |
| 05/12/2011 | US20110110974 Methods and kits for inducing a ctl response using a prime boost regimen |
| 05/12/2011 | US20110110973 Influenza B Vaccines |
| 05/12/2011 | US20110110972 Stimulation of an immune response by enantiomers of cationic lipids |
| 05/12/2011 | US20110110971 Antigen-and-drug vehicle comprising synthetic peptide, and mucosal vaccine using the same |
| 05/12/2011 | US20110110970 Chimeric vaccines |
| 05/12/2011 | US20110110969 Peptide vaccines against group a streptococci |
| 05/12/2011 | US20110110968 Human optimized Bacillus anthracis protective antigen |
| 05/12/2011 | US20110110967 Gas57 mutant antigens and gas57 antibodies |
| 05/12/2011 | US20110110966 Novel immunogenic proteins of leptospira |
| 05/12/2011 | US20110110965 Compositions that induce t cell help |
| 05/12/2011 | US20110110963 Gene encoding labyrinthin, a marker for cancer |
| 05/12/2011 | US20110110962 Novel Immunoadjuvant Flagellin-Based Compounds and Use Thereof |
| 05/12/2011 | US20110110961 Prolyl hydroxylase inhibitors |
| 05/12/2011 | US20110110960 Mannose-6-phosphate receptor mediated gene transfer into muscle cells |
| 05/12/2011 | US20110110959 Anti-p2x7 peptides and epitopes |
| 05/12/2011 | US20110110958 Compositions and methods for the treatment of neoplasia |
| 05/12/2011 | US20110110957 Phenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as bace-1 inhibitors, compositions, and their use |
| 05/12/2011 | US20110110956 Heparin-Binding Epidermal Growth Factor-like Growth Factor Binding Proteins |
| 05/12/2011 | US20110110955 Antibody cancer immunotherapy |
| 05/12/2011 | US20110110954 Anthrax compositions and methods of use and production |
| 05/12/2011 | US20110110953 Compound and method for treatment of chronic transplant rejection |
| 05/12/2011 | US20110110952 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer |
| 05/12/2011 | US20110110951 Isolation of five novel genes coding for new fc receoptrs-type melanoma involved in the pathogenesis of lymphoma/melanoma |
| 05/12/2011 | US20110110950 Therapeutic regimens for BAFF antagonists |
| 05/12/2011 | US20110110949 Nesfatin-1 specific antibody and the use thereof, and nesfatin specific antibody and the use thereof |
| 05/12/2011 | US20110110948 Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors |
| 05/12/2011 | US20110110947 Viral chemokine-antigen fusion proteins |
| 05/12/2011 | US20110110946 Soluble receptor br43x2 and methods of using |
| 05/12/2011 | US20110110945 Immunoglobulin Fusion Proteins and Methods of Making |
| 05/12/2011 | US20110110944 Anti-alk1 antibodies and uses thereof |
| 05/12/2011 | US20110110943 Soluble receptor br43x2 and methods of using |
| 05/12/2011 | US20110110942 Method of promoting dendritic spine density |
| 05/12/2011 | US20110110941 Wortmannin Analogs and Methods of Using Same in Combination with Chemotherapeutic Agents |
| 05/12/2011 | US20110110940 Methods for Enhancing the Efficacy of Vascular Disrupting Agents |
| 05/12/2011 | US20110110939 Methods and compositions for the treatment and diagnosis of systemic anthrax infection |
| 05/12/2011 | US20110110938 Compositions and methods for the treatment of immune related diseases |
| 05/12/2011 | US20110110937 Composition and method for introduction of rna interference sequences into targeted cells and tissues |
| 05/12/2011 | US20110110936 Anti-gcc antibody molecules and related compositions and methods |
| 05/12/2011 | US20110110935 Methods and Compositions for Increasing Iduronate 2-Sulfatase Activity in the CNS |
| 05/12/2011 | US20110110934 Treatment of uveitis |
| 05/12/2011 | US20110110933 Ectopic pregnancy treatment |
| 05/12/2011 | US20110110932 Combination treatment for ocular diseases |